Zobrazeno 1 - 5
of 5
pro vyhledávání: '"JIAN-WEI GE"'
Autor:
Fang‐Fei Tao, Zi‐Yu Wang, Ying Wang, Qian‐Ru Lv, Peng‐Peng Cai, Hai‐Wen Min, Jian‐Wei Ge, Chun‐Yu Yin, Rui Cheng
Publikováno v:
CNS Neuroscience & Therapeutics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::720d6708820fa22886f4cc5c6c9691e3
https://doi.org/10.1111/cns.14185
https://doi.org/10.1111/cns.14185
Autor:
Zhen Lan, Jiang-Nan Li, Sheng-Nan Xia, Zhi-Wei Xue, Xinyu Bao, Pinyi Liu, Jian-Wei Ge, Xiaolei Zhu, Yun Xu, Linjie Yu, Yue Gu, Shi-Ji Deng
Publikováno v:
CNS Neuroscience & Therapeutics
Aims Microglia‐mediated neuroinflammation plays an important role in the pathological process of ischemic stroke, and the effect of imperatorin on post‐stroke neuroinflammation is not fully understood. Methods Primary microglia were treated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22143bbf496b45d3c04afc463a12e135
https://pubmed.ncbi.nlm.nih.gov/34674376
https://pubmed.ncbi.nlm.nih.gov/34674376
Autor:
Wen‑Hao Xiong, Pin Guo, Guisong Wang, Ying‑Ying Lin, Xi Yang, Yong‑Ming Qiu, Lin Shen, Jian‑Wei Ge, Lie‑Mei Guo, Shuang‑Lin Que, Xiao‑Xiong Li, Quan‑Min Nie
Publikováno v:
Molecular Medicine Reports. 12:6695-6701
Mutations in isocitrate dehydrogenase 1 (IDH1) are found in >70% of secondary glioblastomas and lower-grade gliomas (grades II-III). Among the numerous phenotypic differences between IDH1 mutant and wild-type glioma patients, the most salient is an i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf3ccebb5c4f0aa66e0d40146fa705fa
https://doi.org/10.3892/mmr.2015.4241
https://doi.org/10.3892/mmr.2015.4241
Autor:
Quan-Min, Nie, Ying-Ying, Lin, Xi, Yang, Lin, Shen, Lie-Mei, Guo, Shuang-Lin, Que, Xiao-Xiong, Li, Jian-Wei, Ge, Gui-Song, Wang, Wen-Hao, Xiong, Pin, Guo, Yong-Ming, Qiu
Publikováno v:
Molecular Medicine Reports
Mutations in isocitrate dehydrogenase 1 (IDH1) are found in >70% of secondary glioblastomas and lower-grade gliomas (grades II–III). Among the numerous phenotypic differences between IDH1 mutant and wild-type glioma patients, the most salient is an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f54888f758be9fbdac6e1ab072dc5e47
https://pubmed.ncbi.nlm.nih.gov/26324126
https://pubmed.ncbi.nlm.nih.gov/26324126
Autor:
QUAN-MIN NIE, YING-YING LIN, XI YANG, LIN SHEN, LIE-MEI GUO, SHUANG-LIN QUE, XIAO-XIONG LI, JIAN-WEI GE, GUI-SONG WANG, WEN-HAO XIONG, PIN GUO, YONG-MING QIU
Publikováno v:
Molecular Medicine Reports; 2015, Vol. 12 Issue 5, p6695-6701, 7p